Regulatory Biopharma industry endorses Pazdur for FDA commissioner role Pharmaceutical TechnologyHundreds of biopharma leaders say Dr Richard Pazdur has the necessary qualities to lead the FDA amid a crisis of confidence.Read full story pharminent May 15, 2026 Pharmaceutical Technology Hundreds of biopharma leaders say Dr Richard Pazdur has the necessary qualities to lead the FDA amid a crisis of confidence. Read full story Post navigation Previous: ECO 2026: tirzepatide shows potential for T1D treatmentNext: Lilly UK recruits ex-England cricketer as obesity champion Related Stories Regulatory Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval pharminent September 14, 2026 Regulatory Psychedelic therapies ride wave of public favor into FDA hearing pharminent September 14, 2026 Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026